Skip to Content

SZ 787 (Carbamazepine extended release 200 mg)

Pill imprint SZ 787 has been identified as Carbamazepine extended release 200 mg.

Carbamazepine is used in the treatment of bipolar disorder; trigeminal neuralgia; epilepsy; schizoaffective disorder; borderline personality disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbamazepine extended release 200 mg SZ 787  Front
Carbamazepine extended release 200 mg SZ 787  Back
Carbamazepine extended release 200 mg SZ 787
Discount Card Promo
Carbamazepine extended release
SZ 787
200 mg
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Sandoz Pharmaceuticals Inc
National Drug Code (NDC):

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.